Studies have reported that DGMI significantly activated the PI3K/Akt signaling pathway in vitro and in vivo to promote cell survival and inhibit apoptosis, which might be one mechanism for its efficacy in stroke treatment (Jin et al., 2017; Zhang et al., 2018; Liu et al., 2019). This evidence concerns the gene AKT1 and Stroke.